Joseph Fetterman | Colliers International | Philadelphia

Joseph Fetterman

Executive Vice President | Healthcare and Life Sciences

Call Joseph
View More View Less

About

Professional Summary

Joe joined Colliers International in 2012 to lead and grow Colliers’ Office Brokerage Division.  Today he focuses on providing strategic solutions to local, national and global Health Care, Life Sciences and Corporate clients. Joe’s background in architecture, real estate development and financial analysis provides clients with an experienced professional and strategic leader who integrates  complex factors to create successful results for clients

Joe is a Healthcare Fellow and serves on Colliers National Healthcare Services and Life Sciences Steering Committees. 

Accomplishments

Prior to joining Colliers, Joe was Senior Vice President at Jones Lang LaSalle, where he led the company’s regional higher education, healthcare and public sector consulting and brokerage practices.

Before joining Jones Lang LaSalle, Joe was Senior Vice President and Co-Managing Principal of The Staubach Company in Philadelphia. Projects of note include headquarters for General Instrument (Motorola Broadband), NFL Films, Tyco International, AmeriHealth New Jersey, Parker McCay and regional offices for AIG, U.S. EPA and U.S. GSA.
Joe has managed the acquisition, leasing, and development of more than 4,000,000 SF of office space on behalf of corporate and institutional clients and has developed strategic real estate plans for  Air Products, OKI Data Americas, Organization of American States, Kutztown University, Camden County College, Bancroft NeuroHealth, tAmerican Revolution Center and The Wistar Institute.

 

Education

MBA | The Wharton School
The University of Pennsylvania

BARCH | Architecture
Drexel University

Memberships & Involvements

Urban Land Institute

Board of Directors - Arthur Ashe Youth Tennis and Education, Board of Directors - Pennsylvania Resource Capital, Board of Directors - Philadelphia Regional Board of Economics PA, Campaign Leadership Committee - Salvation Army’s Ray and Joan Kroc Community Center, Member - Mary S. Irick Drexel Society

Clients

ACE Ltd.
AIG
Air Products
AmeriHealth New Jersey
Cellectis 
Chamber of Commerce, Southern NJ
Crozer Keystone Health System
Delaware State University
Goodell DeVries
Insight Global
Morgan Lewis
Motorola Broadband (General Instrument)
NFL Films
OKI Data Americas
Organization of American States
Parker McCay
Pennoni Associates
Philadelphia University
St. Mary Medical Center
Stradley Ronon
Temple University Health System
The Wistar Institute
Tyco International
University of Delaware
Walker & Dunlop

Services

Skills
Healthcare, Life Sciences
Property Type
Healthcare-Medical, Office
Specializations
Law Firm Services Group, Life Sciences Group

My Team

My Team

Featured Research
Jun 24, 2020
Mid-Year Update: COVID-19 Impact on the Life Sciences Real Estate Sector
Lab productivity is recovering. COVID-related investigations are on a fast track. Expansion requirements are back on pace, even exceeding pre-COVID levels.
Read More
Mar 24, 2020
SARS-CoV-2 Impact on the Life Sciences Real Estate Sector
Learn the five trends facing the lab real estate sector as we react to a global pandemic in a new Colliers Life Sciences whitepaper report.
Read More
Feb 25, 2020
In-House or Outsource? Considerations for Biotechs at the Drug Manufacturing Crossroads
In house or outsource to a CDMO? Five considerations for pre-clinical and clinical drug development companies facing critical manufacturing decisions, authored by Joseph Fetterman of the Colliers Life Sciences Practice Group.
Read More
View More
Featured News
Mar 19, 2019
UCART Manufacturing Facility Site Selection
We structured a lease for Cellectis, a Paris based clinical-stage biopharmaceutical company, to create an 82,000 square foot commercial-scale manufacturing facility named IMPACT (Innovative Manufacturing Plant for Allogeneic Cellular Therapies) in Raleigh, North Carolina, for clinical and commercial production of Cellectis’ leading allogeneic UCART products.
Read More
Mar 13, 2019
Colliers International Concludes 82,985 SF Lease for New UCART Manufacturing Facility in Raleigh, North Carolina
Cellectis, a clinical-stage biopharmaceutical company that harnesses the immune system to target and eradicate cancer cells, has announced that it has entered into a lease agreement for an 82,000 square foot commercial-scale manufacturing facility named IMPACT (Innovative Manufacturing Plant for Allogeneic Cellular Therapies) in Raleigh, North Carolina, for clinical and commercial production of Cellectis’ leading allogeneic UCART products.
Read More
View More

How can I help you?

An unexpected error has occurred. Please try again.
Your request has been submitted.
Someone will contact you shortly.